| |
| |
|
| Insider
Information: |
Versant Side Fund Iii, L.p. |
| Relationship: |
10% Owner |
| City: |
Menlo Park |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
4,483,954 |
|
|
Indirect Shares
|
3,317,488 |
|
|
| Direct
Value |
$669,107 |
|
|
|
Indirect Value
|
$728,478 |
|
|
| Total
Shares |
7,801,442 |
|
|
| Total
Value |
$1,397,585 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Trius Therapeutics Inc |
TSRX |
10% Owner |
2010-08-06 |
0 |
2010-08-06 |
3,235,839 |
Premium* |
|
|
Veracyte, Inc. |
VCYT |
10% Owner |
2013-11-04 |
0 |
2013-11-04 |
21,232 |
Premium* |
|
|
Flexion Therapeutics Inc |
FLXN |
10% Owner |
2014-02-11 |
73,367 |
2014-02-11 |
32,413 |
Premium* |
|
|
Ocular Therapeutix, Inc |
OCUL |
10% Owner |
2015-06-15 |
2,202,377 |
2015-06-15 |
13,007 |
Premium* |
|
|
Immune Design Corp. |
IMDZ |
10% Owner |
2014-07-29 |
2,208,210 |
2014-07-29 |
0 |
Premium* |
|
|
Opgen Inc |
OPGN |
10% Owner |
|
0 |
2015-05-08 |
14,997 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
17 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| OCUL |
Ocular Therapeutix, Inc |
10% Owner |
– – • |
2015-06-15 |
4 |
S |
$22.00 |
$41,316 |
I/I |
(1,878) |
13,007 |
0 |
- |
|
| OCUL |
Ocular Therapeutix, Inc |
10% Owner |
– – • |
2015-06-15 |
4 |
S |
$22.00 |
$6,998,684 |
D/D |
(318,122) |
2,202,377 |
0 |
- |
|
| OCUL |
Ocular Therapeutix, Inc |
10% Owner |
– – • |
2015-06-10 |
4 |
S |
$22.00 |
$55,132 |
I/I |
(2,506) |
14,885 |
0 |
- |
|
| OCUL |
Ocular Therapeutix, Inc |
10% Owner |
– – • |
2015-06-10 |
4 |
S |
$22.00 |
$9,338,868 |
D/D |
(424,494) |
2,520,499 |
0 |
- |
|
| OPGN |
Opgen Inc |
10% Owner |
– – • |
2015-05-08 |
4 |
B |
$6.00 |
$2,479,992 |
I/I |
413,332 |
2,853 |
1.5 |
- |
|
| OPGN |
Opgen Inc |
10% Owner |
– – • |
2015-05-08 |
4 |
A |
$0.00 |
$0 |
I/I |
2,068,286 |
14,997 |
0 |
- |
|
| OPGN |
Opgen Inc |
10% Owner |
– – • |
2015-05-04 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
72,593 |
|
- |
|
| OCUL |
Ocular Therapeutix, Inc |
10% Owner |
– – • |
2014-07-30 |
4 |
A |
$0.00 |
$0 |
I/I |
17,391 |
17,391 |
0 |
- |
|
| OCUL |
Ocular Therapeutix, Inc |
10% Owner |
– – • |
2014-07-30 |
4 |
A |
$0.00 |
$0 |
D/D |
2,944,993 |
2,944,993 |
0 |
- |
|
| IMDZ |
Immune Design Corp. |
10% Owner |
– – • |
2014-07-29 |
4 |
B |
$12.00 |
$2,799,996 |
D/D |
233,333 |
2,208,210 |
2.45 |
- |
|
| IMDZ |
Immune Design Corp. |
10% Owner |
– – • |
2014-07-29 |
4 |
S |
$12.00 |
$2,500,008 |
D/D |
(208,334) |
1,974,877 |
0 |
- |
|
| IMDZ |
Immune Design Corp. |
10% Owner |
– – • |
2014-07-29 |
4 |
A |
$0.00 |
$0 |
D/D |
2,183,211 |
2,183,211 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
10% Owner |
– – • |
2014-02-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
32,413 |
|
- |
|
| FLXN |
Flexion Therapeutics Inc |
10% Owner |
– – • |
2014-02-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
73,367 |
|
- |
|
| VCYT |
Veracyte, Inc. |
10% Owner |
– – • |
2013-11-04 |
4 |
A |
$0.00 |
$0 |
I/I |
3,616,221 |
21,232 |
0 |
- |
|
| TSRX |
Trius Therapeutics Inc |
10% Owner |
– – • |
2010-08-06 |
4 |
B |
$5.00 |
$4,572,645 |
I/I |
914,529 |
3,235,839 |
1.5 |
- |
|
| TSRX |
Trius Therapeutics Inc |
10% Owner |
– – • |
2010-08-06 |
4 |
A |
$0.00 |
$3,260,892 |
I/I |
2,321,310 |
2,321,310 |
0 |
- |
|
17 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
